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Pro-inflammatory cytokines contribute to pancreatic beta
cell apoptosis in type1diabetes at least inpart by inducing endo-
plasmic reticulum (ER) stress and the consequent unfolded pro-
tein response (UPR). It remains to be determined what causes
the transition from “physiological” to “apoptotic” UPR, but
accumulating evidence indicates that signaling by the ER trans-
membrane protein IRE1 is critical for this transition. IRE1
activation is regulated by both intra-ER and cytosolic cues. We
evaluated the role for the presently discovered cytokine-in-
duced and IRE1-interacting protein ubiquitin D (UBD) on the
regulation of IRE1 and its downstream targets. UBD was
identified by use of a MAPPIT (mammalian protein-protein
interaction trap)-based IRE1 interactome screen followed
by comparison against functional genomic analysis of human
and rodent beta cells exposed to pro-inflammatory cytokines.
KnockdownofUBD inhuman and rodent beta cells anddetailed
signal transduction studies indicated that UBDmodulates cyto-
kine-induced UPR/IRE1 activation and apoptosis. UBD ex-
pression is induced by the pro-inflammatory cytokines interleu-
kin (IL)-1 and interferon (IFN)- in rat and human pancreatic
beta cells, and it is also up-regulated in beta cells of inflamed
islets from non-obese diabetic mice. UBD interacts with IRE1
in human and rodent beta cells, modulating IRE1-dependent
activation of JNK and cytokine-induced apoptosis. Our data
suggest that UBD provides a negative feedback on cytokine-in-
duced activation of the IRE1/JNK pro-apoptotic pathway in
cytokine-exposed beta cells.
Endoplasmic reticulum (ER)8 stress and the consequent trig-
gering of the unfolded protein response (UPR) are induced in
human pancreatic beta cells by the pro-inflammatory cytokines
interleukin-1 (IL-1) and tumor necrosis factor- (TNF-), in
combination with interferon- (IFN-), and probably contribute
tobetacell apoptosis in type1diabetes (T1D) (1–3).Markersof the
UPR are expressed in inflamed islets of both non-obese diabetic
(NOD)mice (4, 5) and patients affected by T1D (6).
The UPR is mediated through activation of three ER trans-
membrane proteins as follows: inositol-requiring protein 1
(IRE1), protein kinase RNA-like endoplasmic reticulum
kinase (PERK), and activating transcription factor 6 (ATF6).
These proteins sense the accumulation of unfolded proteins
in the ER lumen and activate mechanisms to restore its
homeostasis (2, 7). Fine-tuning of the activity of these trans-
membrane proteins is provided by signals from the cytosol
(8). In the case of unresolved ER stress, the persistent stim-
ulation of the UPR triggers apoptosis via activation of C/EBP
homologous protein (CHOP), c-Jun N-terminal kinase
(JNK), death protein 5 (DP5), and other pro-apoptotic sig-
nals (9, 10). What determines the transition from “physio-
logical” to “apoptotic” UPR remains to be clarified (8), but
accumulating evidence indicates that the changing nature of
IRE1 signaling is critical for this transition (11). In partic-
ular, IRE1-induced JNK activation is crucial for cytokine-
induced apoptosis in human pancreatic beta cells (12).
Against this background, we used a high-throughput mam-
malian two-hybrid technology, MAPPIT (mammalian protein-
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protein interaction trap) coupled to functional genomic analy-
sis of human and rodent beta cells exposed to IL-1 IFN- to
identify novel cytokine-induced IRE1-interacting proteins
that modulate UPR activation in pancreatic beta cells (13).
Based on this analysis, we selected two candidates for detailed
functional studies: NMI (13) and ubiquitin D (UBD; this study).
UBD (also know as FAT10) is expressed in the immune system
and in some cancer cells (14–17), and its expression is up-reg-
ulated by IFN- and TNF- (18, 19). UBD interacts non-cova-
lently or covalently with different proteins, respectively, modi-
fying their activity (20, 21) or triggering their degradation in the
proteasome (22, 23). Of particular interest in the context of
T1D, the Ubd gene maps to the telomeric region of the human
major histocompatibility complex (MHC), the most important
susceptibility locus for T1D (24, 25). Polymorphisms in the
region of theUbd gene have been associated with autoimmune
diabetes in rat and human (26–29), but this remains to be
confirmed.
We presently show that UBD expression is induced by pro-
inflammatory cytokines in rat and human pancreatic beta cells,
and it is also present in beta cells of inflamed islets from NOD
mice. Of particular importance, we show that UBD interacts
with IRE1 in cytokine-treated human and rodent beta cells,
providing a negative feedback for IRE1-induced activation of
JNK and consequent apoptosis.
Materials andMethods
Culture of Human Islet Cells, FACS-purified Rat Beta Cells,
INS-1E Cells, the Human Beta Cell Line EndoC-H1, and
HEK293T Cells—Human islets from 13 non-diabetic donors
were isolated in Pisa using collagenase digestion and density
gradient purification (30). The donors (seven women and six
men) were 67.1  4.7 years old and had a body mass index of
25.0  1.0 (kg/m2) (Table 1). Beta cell purity, as evaluated by
immunofluorescence for insulin, using a specific anti-insulin
antibody (Table 2), was 52  5.4%. The islets were cultured as
described previously (25, 31).
Isolated pancreatic islets of male Wistar rats (Charles River
Laboratories, Brussels, Belgium) were dispersed, and beta
cells were purified by autofluorescence-activated cell sorting
(FACSAria, BD Bioscience, San Jose, CA) (32), with purity
90%. The rat insulin-producing INS-1E cell line (kindly pro-
vided by Dr. C. Wollheim, University of Geneva, Switzerland)
was cultured in RPMI 1640 GlutaMAX-I medium (Invitrogen,
Paisley, UK) (33).
The humanbeta cell line EndoC-H1 (kindly provided byDr.
R. Scharfmann, University of Paris, France) (34) was cultured as
described previously (12). The human embryonic kidney cells
HEK293T were cultured in DMEM containing 25 mM glucose,
5% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, and
100 sodium pyruvate (Invitrogen).
Cell Treatment and NO Measurement—Cells were exposed
to the following cytokine concentrations, based on previous
dose-response experiments performed by our group (31,
35–37): recombinant human IL-1 (R&D Systems, Abingdon,
UK) 10 units/ml for INS-1E cells or 50 units/ml for human islet
cells, primary rat beta cells, and the EndoC-H1 cells; recom-
binant rat IFN- (R&D Systems) 100 units/ml for INS-1E cells
or 500 units/ml for primary rat beta cells; and human IFN-
(PeproTech, London, UK) 1000 units/ml for human islet cells
or the EndoC-H1 cells. Lower cytokine concentration and
shorter time points were used in the rodent experiments
because rat beta cells are more sensitive to cytokine-induced
damage than human islets (38, 39). Culture medium was col-
lected for nitrite determination (nitrite is a stable product of
NO oxidation) by the Griess method.
TABLE 1
Characteristics of the human islet donors
Subject Age Gender BMI
Beta
cell purity
years kg/m2
C1 84 F 26 73%
C2 59 M 25 70%
C3 72 F 24 62%
C4 51 M NA 37%
C5 76 M 33 68%
C6 49 F 25 72%
C7 66 F 20 36%
C8 81 M 24 29%
C9 82 F 20 34%
C10 75 F 29 24%
C11 69 M 25 85%
C12 85 M 26 39%
C13 23 F 23 46%
X S.E. 67.1 4.7 25.0 1.0 52 5.4%
TABLE 2
Antibodies used in the study
IHC is immunohistochemistry and WB is Western blotting.
Antibody Company Reference Dilution
Insulin Sigma, Bornem, Belgium I2018 IHC, 1:1000
Donkey anti-mouse IgG rhodamine Lucron Bioproducts, De Pinte, Belgium 715-026-156 IHC, 1:200
IRE1 Santa Cruz Biotechnology, Santa Cruz, CA Sc-20790 IP, 1 mg/ml
IRE1 Cell Signaling, Danvers, MA 3294 WB, 1:1000
UBD Proteintech, Chicago 13003-2-AP WB, 1/500 IHC, 1:100
p-SAPK/JNK (T183/Y185) Cell Signaling 9251S WB, 1:1000
SAPK/JNK (56G8) Cell Signaling 9258 WB, 1:1000
JNK1 (2C6) Cell Signaling 708S WB, 1:1000
HRP-conjugated anti-rabbit IgG Lucron Bioproducts 711-036-152 WB, 1:5000
HRP-conjugated anti-mouse IgG Lucron Bioproducts 715-036-150 WB, 1:5000
Alexa Fluor 488 goat anti-mouse Molecular Probes Life Technologies-Invitrogen A-11008 IHC,1/500
Alexa Fluor 546 goat anti-rabbit Molecular Probes Life Technologies-Invitrogen A-11030 IHC, 1/500
Cleaved caspase-3 (D175) (rabbit) Cell Signaling 9661S WB, 1:1000
Cleaved caspase-9 (D353) (rabbit) Cell Signaling 9507S WB, 1:1000
-Actin Cell Signaling 4967 WB, 1:5000
-Tubulin Sigma T9026 WB,1 :5000
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ArrayMAPPIT and Binary MAPPIT—To identify IRE1-in-
teracting proteins, an ArrayMAPPIT screen was performed as
described (40), using as MAPPIT bait the cytoplasmic portion
of IRE1 (amino acids 571–977) (13). The same bait was also
used in the binary MAPPIT analyses, and it was generated
based on the original pSEL MAPPIT bait construct (41).
MAPPIT preys were cloned in the previously described pMG1
vector (42). Briefly, HEK293T cells were transfected with bait,
prey, and STAT3 reporter plasmids (Table 3), and luciferase
activity was measured 48 h after transfection using the lucifer-
ase assay system kit (Promega, Leiden, The Netherlands) on a
TopCount illuminometer. Cells were stimulated with erythro-
poietin (5 ng/ml) 24 h after transfection. To provide further
support for the specificity of the IRE1/UBD interaction, we
performed additional MAPPIT two-hybrid analyses, using
irrelevant protein baits in addition to the empty bait. From the
Cytokine Receptor Laboratory bait collection, we randomly
selected a number of baits that were cloned in the same vector
backbone (pSEL  2L) as the IRE1 bait. In addition, because
PERK, like IRE1, is an ER stress sensor protein with a very
similar topology to that of IRE1, we generated aMAPPIT bait
consisting of the PERK cytosolic portion, similar to the IRE1
bait that was used to show the UBD interaction.
RNA Interference—The siRNAs (30 nM) used in this study are
described inTable 4. Theywere transfected into beta cells using
previously defined optimal conditions (31, 43). After 16 h of
transfection, cells were cultured for a 24- or 48-h recovery
period before exposure to cytokines.
Assessment of Cell Viability—The percentage of viable, apo-
ptotic, and necrotic cells was determined after staining the cells
with the DNA-binding dyes propidium iodide (5g/ml; Sigma,
Bornem, Belgium) and Hoechst dye 33342 (5 g/ml; Sigma). A
minimum of 600 cells was counted for each experimental con-
dition by two independent observers, with one of themunaware
of sample identity. The agreement between findings obtained
by the two observers was always90%. This fluorescence assay
for single cells is quantitative and has been validated by system-
atic comparisons against electron microscopy observations,
ladder formation, and caspase 3/9 activation (31, 44–46).
Western Blot, mRNA Extraction, and Real Time PCR—For
Western blot, cells were washed with cold PBS and lysed using
Laemmli Sample Buffer. Total protein was extracted and
resolved by 8–10% SDS-PAGE, transferred to a nitrocellulose
membrane, and immunoblottedwith the specific antibodies for
the protein of interest (Table 2) as described (31). The densito-
metric values were corrected by the housekeeping proteins
-tubulin or -actin.
Poly(A) mRNA was isolated from cultured cells using the
Dynabeads mRNA DIRECTTM kit (Invitrogen) and reverse-
transcribed as described previously (47, 48). The real time PCR
amplification reactions were done using iQ SYBRGreen Super-
mix on a LightCycler instrument (Roche Diagnostics, Vil-
voorde, Belgium) and on a Rotor-Gene Q (Qiagen, Venlo,
Netherlands), and the concentration of the gene of interest was
calculated as copies perl using the standard curvemethod (47,
49). Gene expression values in human and rat cells were cor-
rected by the housekeeping genes -actin and Gapdh, respec-
tively. Expression of these genes was not affected by cytokine
TABLE 3
Plasmids used in the study
Plasmids Encoding protein
pSEL-IRE1 bait Cytosolic domain of IRE1
pSEL-IRE1K599A bait Cytosolic domain of IRE1 with K599A mutation
pSEL-IRE1Kin bait Kinase domain of IRE1
pSEL-IRE1Ken bait Endonuclease domain of IRE1
pSEL-empty bait Empty
pMG1-UBD prey UBD
pMG1-empty prey Empty
pXP2d2-rPAP1 Luciferase STAT3 reporter plasmid
pMG1-REM2 RAS (RAD and GEM)-like GTP-binding 2 protein
(REM2)
TABLE 4
siRNAs used in the study
Name Type Distributors Sequence
siCTRL Allstar negative control siRNA Qiagen, Venlo, The Netherlands Sequence not provided
Rat siUBD UbdRSS353947 (siU1) BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen 1, 5-CAAUGGCCAUUAAUGACCUUUGACA-3
2, 5-UGUCAAAGGUCAUUAAUGGCCAUUG-3
Rat siUBD UbdRSS353946 (siU2) BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen 1, 5-CCUAAAGGUGGUGAAGCCCAGUGAU-3
2, 5-AUCACUGGGCUUCACCACCUUUAGG-3
Rat siUBD UbdRSS353945 (siU3) BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen 1, 5-GUUCCCAAACCAAGGUCUCUGUGCA-3
2, 5-UGCACAGAGACCUUGGUUUGGGACC-3
Human si-hU1 BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen Sequence not provided
Human si-hU2 BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen Sequence not provided
Rat siIRE1 ON-TARGETplus Thermo Scientific, Chicago, IL 1, CUGAUGACUUCGUGCGCUA
2, GGCCAGCAGAUUAGCGAAU
3, CAGACAAGCACGAGGACGU
4, AAGAUGGACUGGCGGGAGA
Rat siJNK1 BLOCK-iT StealthTM select siRNA Life Technologies-Invitrogen Sequence not provided
TABLE 5
Sequence of the primers used in the study
Primer Forward sequence Reverse sequence
Ubd (rat) 5-GGACCAGATCCTTCTGCTAGA-3 5-ACCTTTAGGGTGAGGTGGATAG-3
UBD (human) 5-CCATCCACCTTACCCTGAAA-3 5-TTTCACTTGTGCCACTGAGC-3
-Actin (human) 5-CTGTACGCCAACACAGTGCT-3 5-GCTCAGGAGGAGCAATGATC-3
Ins-2 (rat) 5-TGTGGTTCTCACTTGGTGGA-3 5-CTCCAGTTGTGCCACTTGTG-3
Gapdh (rat) 5-AGTTCAACGGCACAGTCAAG-3 5-TACTCAGCACCAGCATCACC-3
Xbp1s (rat) 5-GAGTCCGCAGCAGGTG-3 5-GTGTCAGAGTCCATGGGA-3
Ccl-2 (rat) 5-CTTGTGGGCCTGTTGTTCA-3 5-CCAGCCACTCATTGGGATCA-3
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treatment (31, 50). The primers used in this study are provided
in the Table 5.
Immunoprecipitation—Proteins from the EndoC-H1 cells
were collected with cold lysis buffer (20 mM Tris, pH 7.5, 150
mM NaCl, 1% Triton X-100, 2 mM MgCl2, 25 mM NaF, 2 mM
Na3VO4, 2 mM Na4P2O7, 1 mM sodium Gly-phosphate, and
Complete Protease inhibitor mixture, Roche Diagnostics) and
then pre-cleared for 1 h at 4 °C with Dynabeads Protein G
(Novex by Life Technologies, Inc., Oslo, Norway). The same
amounts of protein were then incubated overnight at 4 °C,
either with the anti-IRE1 antibody (Table 2) or normal rabbit
IgG (Santa Cruz Biotechnology, sc-2027) as negative controls.
After incubation for 1 h with Dynabeads Protein G, the com-
plexes were washed five times with cold lysis buffer and then
resuspended in 5 Laemmli Sample Buffer. Immunoprecipi-
tates and total proteins were run in 8–12% SDS-PAGE, trans-
ferred to a nitrocellulose membrane, and immunoblotted with
specific antibodies for the protein of interest (Table 2).
Histology—Pancreas from NOD-SCID (control) mice and
diabetes-prone NODmice were collected at 8, 9, and 13 weeks
of age for NOD-SCID and 3, 8, and 12 weeks for NODmice and
processed and stained as described previously (13). After over-
night incubation at 4 °C with the primary antibody against
UBD, slides were double-stained for insulin. Alexa Fluor fluo-
FIGURE 1. IRE1 interacts with UBD. The IRE1/UBD interaction was confirmed by binary MAPPIT (A) and endogenous co-immunoprecipitation in human
EndoC-H1 cells (B and C). For Binary MAPPIT HEK293T cells were transiently transfected with plasmids encoding IRE1 (IRE1), kinase-defective K599A IRE1
mutant (K599), the kinase domain of IRE1 (Kin), the endoribonuclease domain of IRE1 bait (Ken), or empty bait (Emp), together with an empty vector (gray
bars) or pMG1-UBD prey construct (white bars), combined with the pXP2d2-rPAP1-luciferase reporter. After 24 h, cells were left untreated or stimulated with
erythropoietin (EPO) for 24 h. Luciferase counts of triplicate measurements are expressed as fold induction versus non-stimulated. Results are represented as
aboxplot indicating lowerquartile,median, andhigher quartile,withwhiskers representing the rangeof the remainingdatapoints,n4 (A). INS-1 E cells (B) and
EndoC-H1 cells (C and D) were lysed and proteins collected for immunoprecipitation (IP) with anti-IRE1 antibodies. Nonspecific rabbit IgG was used as a
negative control. IPs and total proteinswere analyzed byWestern blot (WB) using anti-IRE1, anti-UBD, and anti--tubulin antibodies, as indicated. The figures
shown are representative of three independent experiments (B and C). The means S.E. of the optical density analysis of 2–3 independent experiments of
UBD-specific binding to the IRE1 IP comparedwith IgG is shown inD.Ab LC, antibody light chain.@, p 0.05 IgG versus IRE1; ***, p 0.001 IRE1-UBD versus
IRE1-empty; ###, p 0.001 K599-UBD versus K599-empty; †††, p 0.001 Kin-UBD versus Kin-empty; $$, p 0.01 as indicated by bar; one-way ANOVA (A) and
unpaired Student’s t test (D).
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rescent secondary antibodies (Molecular Probes-Invitrogen)
were applied for 1 h at room temperature (Table 2). After
nuclear staining with Hoechst, pancreatic sections were
mounted with fluorescence mounting medium (DAKO,
Glostrup, Denmark). Immunofluorescence was visualized on a
Zeiss microscope (Axio ImagerA1, Zeiss-Vision, Munich, Ger-
many) equipped with a camera (AxioCAM Zeiss) (6).
Ethic Statements—Human islet collection and handling were
approved by the local Ethical Committee in Pisa, Italy. Male
Wistar ratswere housed and used according to the guidelines of
the Belgian Regulations for Animal Care. All experiments were
approved by the local Ethical Committee. NODmice have been
housed at the KULeuven animal facility since 1989. NOD-SCID
mice were also from a stock colony at the KULeuven. All exper-
iments in mice were approved and performed in accordance
with the Ethics Committee of the KULeuven, Leuven, Belgium.
Statistical Analysis—Data are expressed as means  S.E. A
significant difference between experimental conditions was
assessed by one-way ANOVA followed by a paired Student’s t
test with Bonferroni correction. p values  0.05 were consid-
ered statistically significant. The figures are shown as a box plot
indicating lower quartile, median, and higher quartile, with
whiskers representing the range of the remaining data points,
when the number of experiments is 4 for each conditions.
Alternatively, data are represented as points indicating individ-
ual experiments plus the average and the S.E. or bar graph with
indicated S.E., when the number of experiments is4.
Results
UBD Interacts with IRE1—Candidate proteins that interact
with IRE1 and are modified by pro-inflammatory cytokine
treatment in pancreatic beta cells were identified using Array-
MAPPIT (13). UBDwas chosen for detailed signal transduction
studies following additional selection based on the review of the
literature.
A binary MAPPIT analysis confirmed the interaction
between UBD and IRE1 (Fig. 1A). HEK293T cells were co-
transfected with an erythropoietin (EPO) receptor-based
MAPPIT bait protein containing the cytoplasmic portion of
IRE1 (pSEL-IRE1), a FLAG-taggedUBD prey (pMG1-UBD),
and a STAT3-responsive luciferase reporter (pXP2d2-rPAP1).
After stimulation with EPO, the UBD prey induced a 10-fold
increase in luciferase signal as compared with cells co-trans-
fectedwith the empty prey vector. The binaryMAPPIT analysis
was also used to assess the ability of UBD to bind to the kinase-
defective K599A IRE1 mutant (51) and to the different
domains of IRE1 (Fig. 1A, kinase domain (Kin) and endoribo-
nuclease domain (Ken)). After stimulation with EPO, the lucif-
erase signals observed in both kinase-defective K599A IRE1
mutant and IRE1 Kin were comparable with the signal
observed with the wild type IRE1 when combined with the
UBD prey (Fig. 1A). However, the signal obtained with the
IRE1Ken was significantly reduced compared with the IRE1
wild type, suggesting that the endoribonuclease domain of
IRE1 is less important for the interaction between IRE1 and
UBD. These results indicate that the UBD-IRE1 interaction is
independent of the phosphorylated state of IRE1.
The interaction between UBD and IRE1 was further vali-
dated by endogenous co-immunoprecipitation experiments in
INS-1E cells (Fig. 1B) and in human EndoC-H1 cells (Fig. 1, C
andD). Using an anti-IRE1 antibody, we detected UBD in the
immunoprecipitate (IP), as shown by Western blot analysis
(Fig. 1, B and C). In the EndoC-H1 lysate, UBD bound weakly
also to the rabbit IgG (Fig. 1C), but the amount of UBD binding
to IRE1 was 2-fold higher compared with that bound by the
negative control rabbit IgG (Fig. 1D). To confirm the specificity
of the IRE1/UBD interaction, we have performed additional
MAPPIT two-hybrid analyses using irrelevant protein baits in
addition to the empty bait (Fig. 2). Using the 10-fold cutoff
value that we routinely apply for selecting specific MAPPIT
interactions, only PPP3CA would be considered as a specific
UBD interactor in addition to IRE1. To assess whether the
strong signal obtained with IRE1 does not result from better
bait expression, we measured the interaction of the different
baits with UBD in parallel to their interaction with the REM2
protein. The REM2 interaction signal is a measure of the
expression level of each individual bait, as it interacts with the
cytokine backbone of the two-hybrid bait. TheREM2 signalwas
not stronger for IRE1 as compared with the other baits, indi-
cating that IRE1more potently interactswithUBD than any of
the other baits tested.
Inflammatory Signals Increase UBD Expression in Pancreatic
Islet Cells—We confirmed by real time PCR (RT-PCR) our pre-
vious microarray findings (52, 53) indicating that pro-inflam-
matory cytokines induce UBDmRNA expression in rat insulin-
producing cells. Therewas a peak of UBD expression after 16 or
24 h of IL-1  IFN- exposure in INS-1E cells (Fig. 3A) and
FACS-purified rat beta cells (Fig. 3C), respectively, with subse-
quent decrease. This induction was mostly dependent on
IFN-, with only aminor contribution by IL-1 (Fig. 3B). These
findings were reproduced in both human islets and in the
humanbeta cell line EndoC-H1exposed for 24–48h to IL-1
IFN- (Fig. 3,D and E), confirming our previous RNA sequenc-
ing data (25). The observed cytokine-induced increase in UBD
FIGURE 2.UBD specifically interacts with IRE1 in MAPPIT mammalian
two-hybrid analysis. HEK293T cells seeded in 96-well plates were co-
transfected with different bait proteins (gene symbols indicated on the x
axis, all cloned in the pSEL(2L) expression vector) along with the UBD or
REM2 prey proteins and a STAT3 luciferase-based reporter gene. Twenty
four hours after transfection, cells were stimulatedwith vehicle (non-stim-
ulated) or EPO (20 ng/ml) to activate the two-hybrid system. After 18 h
cells were lysed, and luciferase activity was measured. Data are presented
as fold induction (EPO-stimulated over vehicle-stimulated luciferase val-
ues). Average and standard deviation of triplicate measurements are
shown.
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mRNAexpressionwas confirmed at the protein level in EndoC-
H1 cells (Fig. 3, F and G).
To test whether increased UBD expression occurs during
beta cell inflammation in vivo, we evaluated UBD expression in
islets from diabetes-prone NOD mice. Immunofluorescence
staining of pancreatic sections from NOD mice (Fig. 4A)
showed UBD expression in insulin-positive cells of immune-
infiltrated islets at 8 and 12weeks (Fig. 4A, panels h–l), although
UBD was not detected in islets from age-matched, genetically
similar but not diabetes-prone NOD-SCID mice (Fig. 4B, pan-
els b, c, e, f, h, and i). There was also no detectable UBD expres-
sion in islets from BALB/c mice examined at 4, 9 and 13 weeks
of age (data not shown). The observedUBD expression inNOD
mouse islets seems a direct consequence of islet inflammation
(insulitis), because it was not detected in NODmouse islets at 3
weeks of age (Fig. 4A, panels b and c), an age when islets are not
yet invaded by immune cells, and in insulitis-free islets of NOD
mice at 8 weeks of age (Fig. 4A, panels e and f).
UBD Inhibition Does Not Affect IRE1 Endonuclease Activity
in Rat and Human Pancreatic Beta Cells—To understand the
function of cytokine-induced UBD expression on IRE1 activ-
ity, we knocked down (KD) UBD with three different specific
FIGURE 3. IL-1 IFN- induceUBDexpression in rodent andhumanbeta cells. The expression of UBDwas assessed by RT-PCR (A–E) and byWestern blot
(F and G) in INS-1E cells (A and B), FACS-purified rat beta cells (C), human islet cells (D), and the human EndoC-H1 cells (E–G), and normalized by the
housekeeping gene Gapdh (A–C) or -actin (D–G). Cells were left untreated or treated with IL-1 IFN- (ILIFN) at different times, as indicated (A and C–G)
or left untreated or treated with IL-1 (white bar), IFN- (gray bar), and IL-1  IFN- (ILIFN; black bar) for 24 h (B). Results are represented as a box plot
indicating lower quartile, median, and higher quartile, with whiskers representing the range of the remaining data points (A and C–E). One representative
Western blot for UBD (F) and optical density analysis of 6–7 independent experiments are shown (G). Data were normalized against the highest value
(considered as 1) in each independent experiment (G). *, p 0.05; **, p 0.01; ***, p 0.001 versus 0 h or control (ctrl); paired Student’s t test. Data shown are
mean S.E. of 3–7 independent experiments.
UBD Inhibits IRE1/JNK in Beta Cells
JUNE 3, 2016•VOLUME 291•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 12045
 at B
IO
M
ED
ISCH
E BIBLIO
TH
EEK
 on Septem
ber 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
siRNAs. The effects of two of them, siU2 and siU3, are shown in
Fig. 5A; both siRNAs induced a 70% inhibition of UBD
expression following cytokine exposure. UBD KD in INS-1E
cells (Fig. 5, A–C) did not modify cytokine-induced IRE1
endonuclease activity as evaluated by Xbp1 splicing (Xbp1s)
(Fig. 5B) and Ins-2 mRNA degradation (Fig. 5C). These data
were confirmed in human beta cells, where UBD KD (60–80%
inhibition; Fig. 5D) did not change cytokine-induced Xbp1
splicing (Fig. 5E).
UBDModulates IRE1-dependent JNKActivation—Wenext
evaluated whether UBD KD interferes with IRE1-dependent
JNKphosphorylation in beta cells. A decrease ofmore than 70%
FIGURE4. Increased expression of UBD in inflamed islets fromdiabetes-proneNODmice. Pancreatic sections from 3-, 8-, and-12week-old NODmice
were stained for insulin (panels a, d, g, and j, green), UBD (panels b, e, h, and k, red), and Hoechst for nuclear staining (panels c, f, i, and l, blue). Infiltrated
lymphocytes, a sign of insulitis, are indicated by white arrowheads (panels i and l). Insulitis is present at 8 and 12 weeks of age but not at 3 weeks. The
immunofluorescence analysis shows UBD expression in insulin-positive cells in NOD mice at 8 and 12 weeks (panels i and l, yellow) but not at 3 weeks
(panels b and c) or at 8 weeks when insulitis is not present (panels e and f). The images shown are representative of 16  3 islet sections from 3 to 4
different mice per age (A). Pancreatic sections from 8-, 9-, and 13-week-old NOD-SCID mice were stained with antibodies specific for insulin (panels a, d,
and g, green), UBD (panels b, e, and h, red), and with Hoechst for nuclear staining (panels c, f, and i, blue). Immunofluorescence analysis indicates absence
of UBD expression in insulin-positive cells in NOD-SCIDmice (panels c, f, and i, merge). The images shown are representative of 12 3 islet sections from
1 to 3 mice per age (B). Bars, 50 m.
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in UBD protein expression was obtained with three different
siRNAs (Fig. 6,A andB). TheKDofUBD significantly increased
cytokine-induced JNKphosphorylation in INS-1E cells after 2 h
(Fig. 6,C andD) and 8 h of exposure (Fig. 6,E and F). DoubleKD
of UBD and IRE1 reversed the stimulatory effect of UBD
silencing on JNK phosphorylation (Fig. 7, A–D), confirming
that the UBD effects on JNK are IRE1-dependent. This was
confirmed by quantification of the area under the curve for
phospho-JNK expression (Fig. 7D) and was reproduced using a
second siRNA targeting UBD (data not shown).
UBD-dependent JNK Modulation Regulates Cytokine-in-
duced Apoptosis in Pancreatic Beta Cells—JNK has an impor-
tant role in cytokine-induced beta cell apoptosis (12, 54–58). In
line with this, the KD of UBDwith two different siRNAs (Fig. 8,
A, C, and E) significantly increased apoptosis induced by cyto-
kines in INS-1E cells (Fig. 8B) and rat beta cells (Fig. 8,D and F),
as evaluated by nuclear dyes. KD of UBD increased basal apo-
ptosis in INS-1E cells (Fig. 8B), but this was not confirmed in
primary rat beta cells (Fig. 8, D and F) or human beta cells (see
below). UBDKD increased expression of cleaved caspases 3 and
9, suggesting activation of the intrinsic pathway of apoptosis
(Fig. 8, G–I). Importantly, KD of UBD by two independent
siRNAs (Fig. 9,A andC) also augmented cytokine-induced apo-
ptosis in human islet cells (Fig. 9B) and in the EndoC-H1 cells
(Fig. 9D).
In additional experiments we observed that KD of IRE1
(Figs. 10,A andB, and 11A) or JNK1 (Figs. 10,C andD, and 11B)
reversed the pro-apoptotic effect of UBD KD in both control
and cytokine-treated INS-1E cells (Fig. 10, E and F) and FACS-
purified rat beta cells (Fig. 11, E and F), confirming that cell
death induced by UBD silencing in the context of cytokine
exposure is mediated by up-regulation of the IRE1/JNK1
pathway.
UBD Inhibition Does Not Affect NO Production or Expression
of the Chemokine Ccl-2—To investigate whether UBD defi-
ciency inhibits cytokine-inducedNF-B activation and reduces
the induction of NF-B-regulated genes as has been described
in other cell types (61), we measured two NF-B-dependent
phenomena, namely induction of NO formation (measured as
nitrite accumulation in the medium) and expression of the
chemokine Ccl-2 (3). Neither nitrite accumulation nor Ccl-2
expression was modulated by UBD KD in cytokine-treated
INS-1E cells (Fig. 12), arguing against a role for NF-B inhibi-
tion in the above described effects of UBD inhibition.
Discussion
IRE1 and its downstream targets XBP1s and JNK are poten-
tial regulatory molecules in the cross-talk between cytokine-
induced ER stress and beta cell pro-inflammatory responses
and apoptosis (3, 12, 13, 59). The activity of IRE1 is regulated
FIGURE 5. UBD KD does not affect IRE1 endonuclease activity in IL-1  IFN--treated rodent and human beta cells. INS-1E cells (A–C) and
EndoC-H1 cells (D and E) were transfected with siControl (siC) or two different siRNAs targeting rat UBD (siU2 and siU3, A–C) or human UBD (si-hU1 and
si-hU2, D and E). 48 h later, cells were left untreated or treated with IL-1 IFN- (ILIFN) for 24 h (A–E). The expression levels of Ubd (A and D), Xbp1s
(B and E), and Ins-2 (C) were assessed by RT-PCR and normalized by the housekeeping gene Gapdh (A–C) and -actin (D and E). The results are
represented as points that indicate single experiments plus the average and the S.E. (A–C) or as a box plot indicating lower quartile, median, and higher
quartile, with whiskers representing the range of the remaining data points (D and E). *, p 0.05; **, p 0.01; and ***, p 0.001 IL IFN versus siC; #,
p 0.05, and ##, p 0.01 as indicated by bars; one-way ANOVA followed by Student’s paired t test with Bonferroni correction. Data shown are mean
S.E. of 3–5 independent experiments.
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by both signals generated from inside the ER and the cytosol (8,
11, 60). Against this background, we aim to identify novel cyto-
kine-induced IRE1-interacting proteins that modulate UPR
activation in pancreatic beta cells and thus contribute to
inflammation and beta cell death in early T1D. For this pur-
pose, we previously combined a high-throughput mamma-
lian two-hybrid technology, MAPPIT with functional
genomic analysis of human and rodent beta cells exposed to
pro-inflammatory cytokines (13). This allowed the identifi-
cation of two proteins of particular interest, namely NMI
(13) and UBD (this study).
We presently confirmed by quantitative RT-PCR andWest-
ern blot that IL-1  IFN- induce UBD expression in rat
INS-1E cells, FACS-purified rat beta cells, human islet cells, and
in the human beta cell line EndoC-H1. Induction of UBD is
mostly an effect of IFN-, with a minor contribution by IL-1.
Expression of the protein in both clonal rat and human beta
cells indicates that cytokine-induced UBD expression takes
place at least in part at the beta cell level. Immunofluorescence
staining of pancreatic sections from NOD mice showed UBD
expression in insulin-positive cells at 8 and 12 weeks, although
the protein was not detected in islets from age-matched NOD-
SCID mice or pre-insulitis NOD mice, confirming up-regula-
tion of UBD in vivo as a consequence of local inflammation
(insulitis).
It has been described in other cell types that UBD deficiency
abrogates cytokine-induced NF-B activation and reduces the
induction of NF-B-regulated genes (61). It is, however,
unlikely that these effects explain the present observations,
because KD of UBD in beta cells does not affect the expression
FIGURE6.UBDKD increases cytokine-dependent JNKphosphorylation. INS-1E cellswere transfectedwith siControl (siC) or threedifferent siRNAs targeting
UBD (siU1, siU2, and siU3, A–F). 48 h later, cells were left untreated or treated with IL-1 IFN- (ILIFN) for 16 h (A and B). The phosphorylation of JNK was
measured after 2 h (C and D) and 8 h (E and F) of IL-1 IFN- (ILIFN) treatment. Representative Western blots for UBD (A) and phospho-JNK (C and D) and
the optical density analysis of 3–7 independent experiments (B, D, and F) are shown.-Tubulin expressionwas used as loading control. *, p 0.05; **, p 0.01;
***, p  0.001 versus siC untreated; #, p  0.05; ##, p  0.01 as indicated by bars. Paired Student’s t test. Data shown are mean  S.E. of 3–7 independent
experiments.
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of downstream targets of NF-B, such as inducible nitric oxide
synthase and the chemokine (C-Cmotif) ligand 2 (CCL2) CCL2
(Fig. 12).Moreover, down-regulation of NF-B has a protective
effect in cytokine-induced beta cell apoptosis (62), whereas we
presently observed that KD of UBD increases apoptosis in beta
cells.
UBD effects seem to be independent of the phosphorylated
state of IRE1 because UBD interacts with the K599 kinase-
defective mutant IRE1 in the binary MAPPIT. UBD KD in
INS-1E cells and human EndoC-H1 cells does not modify
cytokine-induced IRE1 endonuclease activity as evaluated by
Xbp1 splicing (Xbp1s) and Ins-2 mRNA degradation. This last
result is in linewith the limited capacity of UBD to interact with
the endoribonuclease domain (Ken) of IRE1 in the binary
MAPPIT (Fig. 1A). Themain effect induced by UBDKDwas to
increase JNK activity, with consequent augmentation of apo-
FIGURE 7. Effect of UBD on JNK phosphorylation is IRE1-dependent. INS-1E cells were transfected with siControl (siC), siIRE1 (siIRE1), siUBD (siU2) or
co-transfectedwith siIRE1 siU2. 48 h later, cells were incubatedwith IL-1 IFN- (ILIFN) and analyzed byWestern blot with phospho-JNK (phoJNK), total
JNK, and IRE1 antibodies at the indicated time points. One representative Western blot of five independent experiments (A) and the means  S.E. of the
optical density measurements of the Western blots (B) are shown. -Tubulin expression was used as loading control. The means S.E. of JNK expression in
cytokine-treated cells are shown inC, and the quantitative analysis of the area under the curves (A.U.C.) is shown inD. *, p 0.05; **, p 0.01; and ***, p 0.001
versus siC untreated; @, p 0.05 versus siC IL IFN; #, p 0.05, and ##, p 0.01 as indicated by bars; one-way ANOVA followed by Student’s paired t test with
Bonferroni correction.
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ptosis. Thus, UBD KD increased cytokine-induced JNK phos-
phorylation after 2 and 8 h of exposure. Double KD of UBD and
IRE1 reversed the up-regulation of JNK phosphorylation and
the increase in apoptosis, confirming the regulatory function of
UBD on IRE1-dependent JNK activation in beta cells. Of
interest, our previous findings indicate that another cytosolic
IRE1 regulator, namelyNMI, also inhibits JNK induction. The
discovery that two cytosolic regulators of IRE1 provide spe-
cific negative feedback against IRE1-induced JNK activation
in beta cells (present data and see Ref. 13) confirms the key
biological role of JNK for ER stress-induced beta cell apoptosis.
Induction of ER stress in human beta cells has basic mecha-
nistic differences as compared with rat beta cells (12). Thus,
cytokine-induced ER stress in rat beta cells involves inducible
NOS expression, nitric oxide (NO) production, and consequent
inhibition of the ER Ca2-transporting ATPase SERCA2b (1).
However, inhibition of NO formation does not prevent cyto-
kine-induced ER stress activation and apoptosis in human islets
(12). Moreover, the expression of SERCA-2b is not modified by
cytokines in human islets and in the human EndoC-H1 cells.
Cytokines induce a biphasic JNK activation in human EndoC-
H1 cells, with peaks at 0.5 and 8 h and a parallel activation of
IRE1, which ismoremarked at 8–16 h. KDof IRE1 decreases
JNK phosphorylation in EndoC-H1 cells after both 0.5 and 8 h
of IL-1 IFN- treatment (12) and in INS-1E after both 2 and
8 h (this study) indicating that the IRE1 pathway contributes
to both the early and late JNK activation in cytokine-exposed
beta cells. Suppression of JNK1 expression by siRNAs partially
FIGURE 8. UBD KD increases cytokine-induced apoptosis and caspase cleavage in INS-1E and FACS-purified rat beta cells. INS-1E cells (A, B, and
G–I) and FACS-purified rat beta cells (C–F), were transfectedwith siControl (siC) or three different siUBDs (siU1, siU2, and siU3) as indicated. 48 h later, cells
were left untreated or treated with IL-1 IFN- (ILIFN) as indicated. UBD KD was assessed by RT-PCR (A, C, and E) and normalized by the housekeep-
ing gene Gapdh. Apoptosis was evaluated after 16 h of treatment in INS-1E (B) and after 24 h (D) or 48 h (F) in FACS-purified rat beta cells. Cleaved
caspases (Casp) 3 and 9 weremeasured byWestern blotting after 16 h of cytokine treatment in INS-1E cells (G–I). One representativeWestern blot of five
independent experiments (G) and the densitometry results for cleaved caspase 3 (H) and cleaved caspase 9 (I) are shown. -Tubulin expressionwas used
as a loading control. Results are represented as a box plot indicating lower quartile, median, and higher quartile, with whiskers representing the range
of the remaining data points in A, B, F, H, and I and as points indicating single experiments, plus the average and the S.E. in C–E. *, p 0.05; **, p 0.01;
and ***, p  0.001 versus siC untreated; #, p  0.05; ##, p  0.01; and ###, p  0.001; @@, p  0.01 as indicated by bars; one-way ANOVA followed by
Student’s paired t test with Bonferroni correction.
FIGURE9.UBDKD increases cytokine-inducedapoptosis inhuman islets andhumanEndoC-H1cells.Human islet cells (A andB) and thehumanbeta cell
line EndoC-H1 (C and D) were transfected with siC and two different siUBDs (si-hU1 and si-hU2). 48 h later, cells were left untreated or treated with IL-1
IFN- (ILIFN) for 24 h. UBD KD was evaluated by RT-PCR and normalized by the housekeeping gene -actin (A and C), and apoptosis was analyzed by
propidium iodide/Hoechst staining (B and D). Results are represented as a box plot indicating lower quartile, median, and higher quartile, with whiskers
representing the range of the remaining data points in B–D and as box plot indicating the single experiments, the average, and the S.E. inA. *, p 0.05, and ***,
p  0.001 versus siC untreated; #, p  0.05; ##, p  0.01; and ###, p  0.001 as indicated by bars; one-way ANOVA followed by Student’s paired t test with
Bonferroni correction. n 3–7 independent experiments.
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protects both rat INS-1E and primary beta cells (this study) and
human EndoC-H1 cells against cytokine-induced apoptosis,
confirming the key role for JNK in cytokine toxicity in human
beta cells (12).
The concomitant activation of both JNK and IRE1 after
cytokine exposure in human beta cells, the decrease on JNK
phosphorylation after IRE1 KD, and the modulation of the
IRE1-induced JNK pathway by two cytokine-induced IRE1-
binding proteins (this study and see Ref. 13), all point to the
conclusion that JNK is the major IRE1-regulated pathway in
the cross-talk between ER-stressed/apoptotic beta cells and the
immune system.
The Ubd gene lies in the telomeric region of MHC class I, a
major susceptibility locus for T1D. Polymorphisms in the Ubd
gene have been associatedwith autoimmune diabetes in rat and
human (26–29), but the role of these polymorphisms in the
FIGURE10.KDof IRE1or JNK1protects INS-1Ecells fromcytokine-inducedapoptosis in thecontextofUBDdeficiency. INS-1E cellswere transfectedwith siC,
siIRE1, siU2, or co-transfectedwith siIRE1 siU2 (A, B,and E). 48h later, cellswere left untreatedor incubatedwith IL-1 IFN- (ILIFN) for 16h. TheKDof IRE1and
UBDwasevaluatedbyWesternblot (A) andapoptosisbypropidiumiodide/Hoechststaining(E).OnerepresentativeWesternblotof4–7 independentexperiments (A)
and thedensitometry results for IRE1expression (B) are shown. INS-1E cellswere transfectedwith siC, siJNK1, siU2, or co-transfectedwith siJNK1 siU2 (C,D, and F).
48 h later, cells were left untreated or incubated with IL  IFN for 16 h. The KD of JNK1 was evaluated by Western blot (C and D) and apoptosis by propidium
iodide/Hoechst staining (F). One representative Western blot of five independent experiments (C) and the densitometry results for JNK1 expression (D) are shown.
-Tubulin expression was used as loading control (A–D). Results are represented as a box plot indicating lower quartile, median, and higher quartile, withwhiskers
representing the range of the remaining data points in B, D, E, and F. *, p 0.05, and ***, p 0.001 versus siC untreated; #, p 0.05; ##, p 0.01, and ##, p 0.001 as
indicated by bars. One-way ANOVA followed by Student’s paired t test with Bonferroni correction.
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expression of UBD remains to be clarified. This study indicates
that UBD provides a negative feedback to a key pro-apoptotic
branch of the UPR in the beta cells, namely the activation of
JNK. During a protracted autoimmunity assault, this protective
feedback will be eventually overrun, but it is conceivable that
both UBD (this study) and NMI (13) play an important protec-
FIGURE 11. KD of IRE1 or JNK1 protects rat beta cells from cytokine-induced apoptosis in the context of UBD-deficiency. FACS-purified rat beta cells
were transfected with siControl (siC), siIRE1, siU2, or co-transfected with siIRE1 siU2 (A, C, and E). 48 h later, cells were left untreated or incubated with IL-1
IFN- (ILIFN) for 48 h. The KD of IRE1 (A) and UBD (C) was assessed by RT-PCR and normalized by the housekeeping gene Gapdh. Apoptosis was evaluated
by propidium iodide/Hoechst staining (E). FACS-purified rat beta cells were transfectedwith siC, siJNK1, siU2, or co-transfectedwith siJNK1 siU2 (B, D, and F).
48 h after the transfection, the cells were left untreated or incubated with IL  IFN for 48 h. The KD of JNK1 (B) and UBD (D) was assessed by RT-PCR and
normalizedby thehousekeepinggeneGapdh.Apoptosiswasevaluatedbypropidium iodide/Hoechst staining (F). Resultswerenormalizedagainst thehighest
value in each independent experiment, considered as 1 (A–D). *, p 0.05; **, p 0.01, and ***, p 0.001 versus siC untreated; #, p 0.05; ##, p 0.01, and ###,
p 0.001 versus siC treated; @, p 0.05; @@, p 0.01, and @@@, p 0.001 as indicated by bars. One-way ANOVA followed by Student’s paired t test with
Bonferroni correction. Data shown are mean S.E. of six independent experiments.
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tive role during putative transient periods ofmild inflammation
in the islets, preventing excessive beta cell lost.
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